Trademark Overview
On Thursday, June 11, 2026, a trademark application was filed for OCLEYEM with the United States Patent and Trademark Office. The USPTO has given the OCLEYEM trademark a serial number of 99879235. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 11, 2026. This trademark is owned by Teva Pharmaceuticals International GmbH. The OCLEYEM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical preparations for treatment of the central nervous system; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations, namely, pharmaceuticals preparations for the treatment of ophthalmic diseases; pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions.